New hope for stubborn hand eczema: drug trial shows promise

NCT ID NCT06283550

Completed Disease control Sponsor: Innovaderm Research Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 28 times

Summary

This study tested a daily pill called abrocitinib in 82 adults with moderate to severe chronic hand eczema that didn't get better with steroid creams. The goal was to see if the drug can reduce skin symptoms like redness, scaling, and itching. Researchers also checked for side effects and looked at skin changes using a gentle tape-stripping method.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

INNO-6052 Site 11

Montreal, Quebec, H2X 2V1, Canada
INNO-6052 Site 12

Fredericton, New Brunswick, E3B 1G9, Canada
INNO-6052 Site 13

Cobourg, Ontario, K9A 0Z4, Canada
INNO-6052 Site 15

Pomorskie, Poland
INNO-6052 Site 16

Warsaw, Poland
INNO-6052 Site 17

Lodz, Poland
INNO-6052 Site 18

Osielsko, Poland
INNO-6052 Site 19

Krakow, Poland
INNO-6052 Site 20

Szczecin, Poland
INNO-6052 Site 21

Lublin, Poland
INNO-6052 Site 22

Wroclaw, Poland
INNO-6052 Site 23

Mikołów, Poland

Conditions

Explore the condition pages connected to this study.

CHRONIC HAND ECZEMA